ELAB · PMGC Holdings Inc. · Exempt Offerings
$2.78
-0.03 (-1.07%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding the Company's ability to continue as a going concern. These unaudited condensed consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Management's plans that alleviate substantial doubt about the Company's ability to continue as a going concern include: (a) raising additional debt or equity financing and (b) the acquisition of cash flow generating assets or businesses. Although the Company has been successful in raising funds in the past, and expects to do so in the future, there are no guarantees that it will be able to raise funds as anticipated.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.25M
Shares
809,579
Volume · Oct 21
3443
Avg daily vol (43 sessions)
49.32K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2023-09-22 | New | Other | $549,990 | $249,996 | 06b |
| 2023-09-11 | Amendment | Other | $1,600,000 | $463,589 | 06b |
| 2023-05-31 | Amendment | Other | $1,600,000 | $323,589 | 06b |
| 2023-04-27 | New | Other | $1,600,000 | $293,589 | 06b |
| 2023-03-17 | New | Other | $1,500,000 | $750,000 | 06b |
| 2022-11-01 | Amendment | Biotechnology | $4,299,999 | $2,963,834 | 06b |
| 2022-07-28 | New | Biotechnology | $4,299,999 | $2,115,323 | 06b |
| 2021-12-10 | Amendment | Biotechnology | $2,000,000 | $1,090,577 | 06b |
| 2021-10-14 | Amendment | Biotechnology | $2,000,000 | $732,477 | 06b |
| 2021-10-01 | New | Biotechnology | $138,999 | $138,999 | 06b |
| 2021-10-01 | New | Biotechnology | $2,000,000 | $732,477 | 06b |
Showing 1–11 of 11 filings